Artal Group S.A. Sangamo Therapeutics, Inc Transaction History

Artal Group S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$5.05 - $8.85 $2.05 Million - $3.58 Million	-405,000 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$8.75 - $13.03 $43,750 - $65,150	5,000 Added 1.25%	405,000 $4.36 Million
Q4 2018 Feb 11, 2019	BUY	$9.51 - $16.6 $951,000 - $1.66 Million	100,000 Added 33.33%	400,000 $4.59 Million
Q3 2018 Nov 09, 2018	BUY	$13.05 - $19.05 $1.31 Million - $1.91 Million	100,000 Added 50.0%	300,000 $5.09 Million
Q2 2018 Aug 10, 2018	BUY	$13.9 - $19.8 $695,000 - $990,000	50,000 Added 33.33%	200,000 $2.84 Million
Q1 2018 May 10, 2018	BUY	$16.7 - $26.35 $2.51 Million - $3.95 Million	150,000 New	150,000 $2.85 Million

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $368M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.